Literature DB >> 3491840

Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy.

N T O'Connor, J A Crick, J S Wainscoat, K C Gatter, H Stein, B Falini, D Y Mason.   

Abstract

The arrangement of the T cell receptor and immunoglobulin genes was analysed in lymphoid tissue biopsy specimens from 25 cases of angioimmunoblastic lymphadenopathy. Nineteen cases showed a rearrangement of the gene coding for the beta chain of the T cell receptor, and in one case a clonal rearrangement of immunoglobulin genes was shown (in which the T cell receptor gene was in a germline configuration). These findings indicate that a monoclonal T cell proliferation is present in most cases of angioimmunoblastic lymphadenopathy, and they also correlate with the fact that some patients who present with this disorder subsequently develop a T cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491840      PMCID: PMC1140768          DOI: 10.1136/jcp.39.11.1229

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

2.  Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature.

Authors:  R S Neiman; P Dervan; C Haudenschild; R Jaffe
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

3.  Malignant lymphoma arising in angioimmunoblastic lymphadenopathy.

Authors:  B N Nathwani; H Rappaport; E M Moran; G A Pangalis; H Kim
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

4.  Immunologic and electronmicroscopic characteristics of a case of immunoblastic lymphadenopathy.

Authors:  M Paulutke; P Khilanani; R Weise
Journal:  Am J Clin Pathol       Date:  1976-06       Impact factor: 2.493

5.  Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature.

Authors:  M H Cullen; A G Stansfeld; R T Oliver; T A Lister; J S Malpas
Journal:  Q J Med       Date:  1979-01

6.  Angioimmunoblastic lymphadenopathy with dysproteinemia. A pathogenetic link between lymphoid proliferation and malignant lymphoma.

Authors:  A Z Bluming; H G Cohen; A Saxon
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

7.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

Authors:  A Arnold; J Cossman; A Bakhshi; E S Jaffe; T A Waldmann; S J Korsmeyer
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

8.  Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma.

Authors:  M L Cleary; J Chao; R Warnke; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas.

Authors:  V Bertness; I Kirsch; G Hollis; B Johnson; P A Bunn
Journal:  N Engl J Med       Date:  1985-08-29       Impact factor: 91.245

10.  Immunological studies in angioimmunoblastic lymphadenopathy.

Authors:  A Skibin; T Yeremiyahu; A Keynan; M R Quastel
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more
  13 in total

1.  [Application of digital pathology tools. An unusual case of non-Hodgkin lymphoma].

Authors:  A-S K Meyer; F E Dallenbach; G Lienert; P Möller; J K Lennerz
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

2.  Atypical immunoproliferative disorders: when of age?

Authors:  G Frizzera
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

3.  Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy.

Authors:  J L Smith; E Hodges; C T Quin; K P McCarthy; D H Wright
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

4.  Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy.

Authors:  A C Feller; H Griesser; C V Schilling; H H Wacker; F Dallenbach; H Bartels; R Kuse; T W Mak; K Lennert
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor- beta gene rearrangements.

Authors:  K Willenbrock; A Roers; C Seidl; H H Wacker; R Küppers; M L Hansmann
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 6.  Neoplasms of follicular helper T-cells: an insight into the pathobiology.

Authors:  Surabhi Jain; Saumyaranjan Mallick; Prashant Ramteke; Ajay Gogia
Journal:  Am J Blood Res       Date:  2022-06-20

7.  Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues.

Authors:  J Lorenzen; G Li; M Zhao-Höhn; C Wintzer; R Fischer; M L Hansmann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.

Authors:  K Ohshima; M Kikuchi; M Hashimoto; M Kozuru; N Uike; S Kobari; Y Masuda; Y Sumiyoshi; S Yoneda; M Takeshita
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Atypical angioimmunoblastic T-cell lymphomas masquerading as systemic polyclonal B-immunoblastic proliferation.

Authors:  Bhavesh Papadi; Jacek M Polski; David R Clarkson; Theresa O Liu-Dumlao
Journal:  Virchows Arch       Date:  2012-07-12       Impact factor: 4.064

Review 10.  Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.

Authors:  Qing-Xu Yang; Xiao-Juan Pei; Xiao-Ying Tian; Yang Li; Zhi Li
Journal:  Diagn Pathol       Date:  2012-01-19       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.